Bioten Co., Ltd. (XKON:289170)
South Korea · Delayed Price · Currency is KRW 2,995.00
+20.00 (0.67%)
At close: Jun 19, 2026
Bioten Market Cap
Bioten has a market cap or net worth of 10.71 billion as of June 18, 2026. Its market cap has decreased by -19.05% in one year.
Market Cap
10.71B
Enterprise Value
n/a
Revenue
10.71B
Ranking
n/a
PE Ratio
9.10
Stock Price
2,995.00
Market Cap Chart
Since October 13, 2023, Bioten's market cap has decreased from 23.56B to 10.71B, a decrease of -54.54%. That is a compound annual growth rate of -25.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 10.71B | -15.87% |
| Dec 30, 2025 | 12.73B | -29.50% |
| Dec 30, 2024 | 18.06B | 65.39% |
| Dec 28, 2023 | 10.92B | -53.65% |
| Oct 13, 2023 | 23.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Baskhanbio Pharma | 24.56B |
| Seoul Pharma | 24.31B |
| Daesung Microbiological Labs. | 24.28B |
| Hurum | 22.21B |
| BIFIDO | 20.70B |
| Union Korea Pharm | 19.70B |
| WooGene B&G | 17.57B |
| Kwangdong Healthbio | 16.42B |